Tamoxifen Citrate Powder
NDC Package 65319-1051-2
Package Information
Tamoxifen Citrate powders is tamoxifen is used to treat breast cancer. This formulation utilizes a powder delivery system. Marketed by Chemische Fabrik Berg Gmbh, this product is identified by NDC 65319-1051.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 65319 - Chemische Fabrik Berg Gmbh
- 65319-1051 -
- 65319-1051-2 - 10 kg in 1 DRUM
- 65319-1051 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (65319-1051). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65319-1051-2 identifies a specific commercial package of 10 kg in 1 drum of Tamoxifen Citrate (UNFINISHED drug), a bulk ingredient labeled by Chemische Fabrik Berg Gmbh. This powder is formulated for use and contains tamoxifen citrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chemische Fabrik Berg Gmbh on April 01, 2020. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Tamoxifen is used to treat breast cancer. It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue.
How is this Chemische Fabrik Berg Gmbh product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65319105102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.